|
1
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ekbom A, McLaughlin JK and Nyrén O:
Pancreatitis and the risk of pancreatic cancer. N Engl J Med.
329:1502–1503. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guerra C, Schuhmacher AJ, Cañamero M,
Grippo PJ, Verdaguer L, Pérez-Gallego L, Dubus P, Sandgren EP and
Barbacid M: Chronic pancreatitis is essential for induction of
pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.
Cancer Cell. 11:291–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morris JP IV, Cano DA, Sekine S, Wang SC
and Hebrok M: Beta-catenin blocks Kras-dependent reprogramming of
acini into pancreatic cancer precursor lesions in mice. J Clin
Invest. 120:508–520. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hruban RH, Wilentz RE and Maitra A:
Identification and analysis of precursors to invasive pancreatic
cancer. Methods Mol Med. 103:1–13. 2005.PubMed/NCBI
|
|
6
|
De La OJP, Emerson LL, Goodman JL, Froebe
SC, Illum BE, Curtis AB and Murtaugh LC: Notch and Kras reprogram
pancreatic acinar cells to ductal intraepithelial neoplasia. Proc
Natl Acad Sci USA. 105:pp. 18907–18912. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shih HP, Kopp JL, Sandhu M, Dubois CL,
Seymour PA, Grapin-Botton A and Sander M: A Notch-dependent
molecular circuitry initiates pancreatic endocrine and ductal cell
differentiation. Development. 139:2488–2499. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kopp JL, von Figura G, Mayes E, Liu FF,
Dubois CL, Morris JP IV, Pan FC, Akiyama H, Wright CV, Jensen K, et
al: Identification of Sox9-dependent acinar-to-ductal reprogramming
as the principal mechanism for initiation of pancreatic ductal
adenocarcinoma. Cancer Cell. 22:737–750. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prévot PP, Simion A, Grimont A, Colletti
M, Khalaileh A, Van den Steen G, Sempoux C, Xu X, Roelants V, Hald
J, et al: Role of the ductal transcription factors HNF6 and Sox9 in
pancreatic acinar-to-ductal metaplasia. Gut. 61:1723–1732. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grimont A, Pinho AV, Cowley MJ, Augereau
C, Mawson A, Giry-Laterrière M, Van den Steen G, Waddell N, Pajic
M, Sempoux C, et al: SOX9 regulates ERBB signalling in pancreatic
cancer development. Gut. 64:1790–1799. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ardito CM, Grüner BM, Takeuchi KK,
Lubeseder-Martellato C, Teichmann N, Mazur PK, Delgiorno KE,
Carpenter ES, Halbrook CJ, Hall JC, et al: EGF receptor is required
for KRAS-induced pancreatic tumorigenesis. Cancer Cell. 22:304–317.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Navas C, Hernández-Porras I, Schuhmacher
AJ, Sibilia M, Guerra C and Barbacid M: EGF receptor signaling is
essential for k-ras oncogene-driven pancreatic ductal
adenocarcinoma. Cancer Cell. 22:318–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Collins MA, Yan W, Sebolt-Leopold JS and
Pasca di Magliano M: MAPK signaling is required for
dedifferentiation of acinar cells and development of pancreatic
intraepithelial neoplasia in mice. Gastroenterology.
146:822–834.e7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu CY, Carpenter ES, Takeuchi KK, Halbrook
CJ, Peverley LV, Bien H, Hall JC, DelGiorno KE, Pal D, Song Y, et
al: PI3K regulation of RAC1 is required for KRAS-induced pancreatic
tumorigenesis in mice. Gastroenterology. 147:1405–1416.e7. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Corcoran RB, Contino G, Deshpande V,
Tzatsos A, Conrad C, Benes CH, Levy DE, Settleman J, Engelman JA
and Bardeesy N: STAT3 plays a critical role in KRAS-induced
pancreatic tumorigenesis. Cancer Res. 71:5020–5029. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lesina M, Kurkowski MU, Ludes K, Rose-John
S, Treiber M, Klöppel G, Yoshimura A, Reindl W, Sipos B, Akira S,
et al: Stat3/Socs3 activation by IL-6 transsignaling promotes
progression of pancreatic intraepithelial neoplasia and development
of pancreatic cancer. Cancer Cell. 19:456–469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fukuda A, Wang SC, Morris JP IV, Folias
AE, Liou A, Kim GE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ, et
al: Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma
initiation and progression. Cancer Cell. 19:441–455. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Morris JP IV, Yan W, Schofield
HK, Gurney A, Simeone DM, Millar SE, Hoey T, Hebrok M and Pasca di
Magliano M: Canonical wnt signaling is required for pancreatic
carcinogenesis. Cancer Res. 73:4909–4922. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pasca di Magliano M, Sekine S, Ermilov A,
Ferris J, Dlugosz AA and Hebrok M: Hedgehog/Ras interactions
regulate early stages of pancreatic cancer. Genes Dev.
20:3161–3173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brabletz S, Bajdak K, Meidhof S, Burk U,
Niedermann G, Firat E, Wellner U, Dimmler A, Faller G, Schubert J
and Brabletz T: The ZEB1/miR-200 feedback loop controls Notch
signalling in cancer cells. EMBO J. 30:770–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang F, Sloss C, Zhang X, Lee SW and
Cusack JC: Membrane-bound heparin-binding epidermal growth factor
like growth factor regulates E-cadherin expression in pancreatic
carcinoma cells. Cancer Res. 67:8486–8493. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rhim AD, Mirek ET, Aiello NM, Maitra A,
Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK,
Vonderheide RH, et al: EMT and dissemination precede pancreatic
tumor formation. Cell. 148:349–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Middleton E Jr, Kandaswami C and
Theoharides TC: The effects of plant flavonoids on mammalian cells:
Implications for inflammation, heart disease, and cancer. Pharmacol
Rev. 52:673–751. 2000.PubMed/NCBI
|
|
24
|
Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke
FC, Huang YT and Lee MT: The antitumor activities of flavonoids. In
Vivo. 19:895–909. 2005.PubMed/NCBI
|
|
25
|
Jia Z, Nallasamy P, Liu D, Shah H, Li JZ,
Chitrakar R, Si H, McCormick J, Zhu H, Zhen W and Li Y: Luteolin
protects against vascular inflammation in mice and
TNF-alpha-induced monocyte adhesion to endothelial cells via
suppressing IΚBα/NF-κB signaling pathway. J Nutr Biochem.
26:293–302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi RX, Ong CN and Shen HM: Luteolin
sensitizes tumor necrosis factor-alpha-induced apoptosis in human
tumor cells. Oncogene. 23:7712–7721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hong Z, Cao X, Li N, Zhang Y, Lan L, Zhou
Y, Pan X, Shen L, Yin Z and Luo L: Luteolin is effective in the
non-small cell lung cancer model with L858R/T790M EGF receptor
mutation and erlotinib resistance. Br J Pharmacol. 171:2842–2853.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang X, Dai S, Dai J, Xiao Y, Bai Y, Chen
B and Zhou M: Luteolin decreases invasiveness, deactivates STAT3
signaling, and reverses interleukin-6 induced
epithelial-mesenchymal transition and matrix metalloproteinase
secretion of pancreatic cancer cells. Onco Targets Ther.
8:2989–3001. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Seymour PA, Freude KK, Tran MN, Mayes EE,
Jensen J, Kist R, Scherer G and Sander M: SOX9 is required for
maintenance of the pancreatic progenitor cell pool. Proc Natl Acad
Sci USA. 104:pp. 1865–1870. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rau B, Paszkowski A, Lillich S, Baumgart
K, Möller P and Beger HG: Differential effects of
caspase-1/interleukin-1beta-converting enzyme on acinar cell
necrosis and apoptosis in severe acute experimental pancreatitis.
Lab Invest. 81:1001–1013. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reid LE and Walker NI: Acinar cell
apoptosis and the origin of tubular complexes in caerulein-induced
pancreatitis. Int J Exp Pathol. 80:205–215. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bagli E, Stefaniotou M, Morbidelli L,
Ziche M, Psillas K, Murphy C and Fotsis T: Luteolin inhibits
vascular endothelial growth factor-induced angiogenesis: Inhibition
of endothelial cell survival and proliferation by targeting
phosphatidylinositol 3′-kinase activity. Cancer Res. 64:7936–7946.
2004. View Article : Google Scholar : PubMed/NCBI
|
